Strontium inhibits osteoclastogenesis by enhancing LRP6 and β-catenin-mediated OPG targeted by miR-181d-5p

Strontium is a drug with the bone formation and anti-resorption effects on bone. The underlying mechanisms for the dual effect of strontium on bone metabolism, especially for the anti-resorption effects remain unknown. Thus, we aim to investigate the mechanisms of effects of strontium on osteoclasto...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:J Cell Commun Signal
Hlavní autoři: Sun, Tianhao, Li, Zhaoyang, Zhong, Xing, Cai, Zhe, Ning, Ziyu, Hou, Tianheng, Xiong, Lifeng, Feng, Yu, Leung, Frankie, Lu, William W., Peng, Songlin
Médium: Artigo
Jazyk:Inglês
Vydáno: Springer Netherlands 2018
Témata:
Research Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6381380/
https://ncbi.nlm.nih.gov/pubmed/30009331
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s12079-018-0478-y
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky